Principal Financial Group Inc Nuvation Bio Inc. Transaction History

Principal Financial Group Inc

$176 Billion
Q2 2025

A detailed history of Principal Financial Group Inc transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 17,141 shares of NUVB stock, worth $88,276. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,141

Previous 11,758 45.78%

Holding current value

$88,276

Previous $20,000 65.0%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	BUY	$1.66 - $2.53 $8,935 - $13,618	5,383 Added 45.78%	17,141 $33,000
Q1 2025 Apr 28, 2025	BUY	$1.76 - $3.25 $2,849 - $5,261	1,619 Added 15.97%	11,758 $20,000
Q4 2024 Jan 31, 2025	BUY	$2.01 - $3.01 $20,379 - $30,518	10,139 New	10,139 $26,000
Q3 2024 Oct 31, 2024	SELL	$2.3 - $3.83 $30,930 - $51,505	-13,448 Reduced 51.82%	12,502 $28,000
Q2 2024 Jul 29, 2024	BUY	$2.58 - $3.69 $24,775 - $35,435	9,603 Added 58.74%	25,950 $75,000
Q1 2024 Apr 29, 2024	SELL	$1.46 - $3.97 $1,749 - $4,756	-1,198 Reduced 6.83%	16,347 $59,000
Q4 2023 Feb 07, 2024	SELL	$0.96 - $1.53 $2,789 - $4,446	-2,906 Reduced 14.21%	17,545 $26,000
Q3 2023 Nov 02, 2023	BUY	$1.26 - $2.1 $6,278 - $10,464	4,983 Added 32.21%	20,451 $27,000
Q2 2023 Aug 07, 2023	SELL	$1.56 - $1.84 $51,862 - $61,170	-33,245 Reduced 68.25%	15,468 $27,000
Q1 2023 May 09, 2023	BUY	$1.6 - $2.48 $5,600 - $8,680	3,500 Added 7.74%	48,713 $80,000
Q4 2022 Feb 09, 2023	BUY	$1.68 - $2.5 $13,937 - $20,740	8,296 Added 22.47%	45,213 $86,000
Q3 2022 Nov 09, 2022	BUY	$0.29 - $4.04 $1,854 - $25,835	6,395 Added 20.95%	36,917 $82,000
Q2 2022 Aug 10, 2022	SELL	$3.24 - $5.85 $66,539 - $120,141	-20,537 Reduced 40.22%	30,522 $99,000
Q1 2022 May 09, 2022	BUY	$4.6 - $8.83 $832 - $1,598	181 Added 0.36%	51,059 $268,000
Q4 2021 Feb 09, 2022	BUY	$7.75 - $10.05 $296,112 - $383,990	38,208 Added 301.56%	50,878 $433,000
Q3 2021 Nov 09, 2021	BUY	$7.78 - $10.0 $98,572 - $126,700	12,670 New	12,670 $126,000

Others Institutions Holding NUVB

# of Institutions

195

Shares Held

168M

Call Options Held

2.31M

Put Options Held

221K

View Full List

About Nuvation Bio Inc.

Ticker NUVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 217,244,000
Market Cap $1.12B
Description
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...

More about NUVB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account

Principal Financial Group Inc Nuvation Bio Inc. Transaction History